Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7555731

Concept 2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
Key financial data of group
Business results of group
Net sales
72,886,000,000 JPY
72,984,000,000 JPY
75,946,000,000 JPY
76,034,000,000 JPY
73,929,000,000 JPY
74,979,000,000 JPY
87,619,000,000 JPY
89,232,000,000 JPY
92,549,000,000 JPY
94,165,000,000 JPY
Ordinary profit (loss)
8,930,000,000 JPY
8,727,000,000 JPY
17,866,000,000 JPY
17,542,000,000 JPY
18,178,000,000 JPY
18,222,000,000 JPY
26,851,000,000 JPY
26,946,000,000 JPY
24,850,000,000 JPY
24,972,000,000 JPY
Profit (loss) attributable to owners of parent
5,440,000,000 JPY
9,549,000,000 JPY
13,405,000,000 JPY
19,370,000,000 JPY
17,775,000,000 JPY
Comprehensive income
5,475,000,000 JPY
9,563,000,000 JPY
16,532,000,000 JPY
17,487,000,000 JPY
16,782,000,000 JPY
Net assets
136,563,000,000 JPY
136,836,000,000 JPY
138,325,000,000 JPY
136,590,000,000 JPY
136,257,000,000 JPY
134,954,000,000 JPY
128,468,000,000 JPY
128,697,000,000 JPY
121,131,000,000 JPY
120,948,000,000 JPY
Total assets
163,747,000,000 JPY
166,328,000,000 JPY
165,181,000,000 JPY
161,798,000,000 JPY
163,332,000,000 JPY
162,327,000,000 JPY
157,875,000,000 JPY
156,253,000,000 JPY
155,985,000,000 JPY
154,347,000,000 JPY
Net assets per share
3,644.33
3,636.17
3,642.34
3,611.75
3,555.93
3,521.92
3,301.09
3,306.96
3,049.78
3,045.17
Basic earnings (loss) per share
180.07
144.80
260.61
251.43
346.63
347.37
493.31
494.89
443.80
445.78
Diluted earnings per share
Equity-to-asset ratio
0.834 xbrli:pure
0.819 xbrli:pure
0.834 xbrli:pure
0.844 xbrli:pure
0.834 xbrli:pure
0.831 xbrli:pure
0.814 xbrli:pure
0.824 xbrli:pure
0.777 xbrli:pure
0.784 xbrli:pure
Rate of return on equity
0.050 xbrli:pure
0.040 xbrli:pure
0.073 xbrli:pure
0.070 xbrli:pure
0.101 xbrli:pure
0.101 xbrli:pure
0.155 xbrli:pure
0.155 xbrli:pure
0.151 xbrli:pure
0.151 xbrli:pure
Price-earnings ratio
20.5 xbrli:pure
25.5 xbrli:pure
14.9 xbrli:pure
15.5 xbrli:pure
12.5 xbrli:pure
12.5 xbrli:pure
10.2 xbrli:pure
10.2 xbrli:pure
11.3 xbrli:pure
11.3 xbrli:pure
Net cash provided by (used in) operating activities
9,253,000,000 JPY
13,336,000,000 JPY
14,380,000,000 JPY
27,468,000,000 JPY
21,129,000,000 JPY
Net cash provided by (used in) investing activities
-2,627,000,000 JPY
-7,888,000,000 JPY
-1,644,000,000 JPY
-2,528,000,000 JPY
-5,744,000,000 JPY
Net cash provided by (used in) financing activities
-6,990,000,000 JPY
-8,129,000,000 JPY
-8,752,000,000 JPY
-10,173,000,000 JPY
-9,524,000,000 JPY
Cash and cash equivalents
74,260,000,000 JPY
74,625,000,000 JPY
77,305,000,000 JPY
73,322,000,000 JPY
58,555,000,000 JPY
Number of employees
1 xbrli:pure
1,116 xbrli:pure
1,117 xbrli:pure
1 xbrli:pure
1,129 xbrli:pure
1,130 xbrli:pure
1,164 xbrli:pure
1,152 xbrli:pure
1,215 xbrli:pure
1,207 xbrli:pure
1,268 xbrli:pure
1,258 xbrli:pure
1,341 xbrli:pure
1,333 xbrli:pure
Average number of temporary employees
xbrli:pure
192 xbrli:pure
192 xbrli:pure
xbrli:pure
194 xbrli:pure
194 xbrli:pure
213 xbrli:pure
211 xbrli:pure
225 xbrli:pure
224 xbrli:pure
242 xbrli:pure
241 xbrli:pure
262 xbrli:pure
260 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.